Company Medviz Srl with Fiscal Code 35395434
recorded a turnover of 2024 of
220.843,
with a net profit of
141.832
and having an average number of employees of
2.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Medviz Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
-
23.040
83.481
116.796
138.446
148.978
143.971
145.145
183.981
220.843
Total Income - EUR
-
23.040
83.499
116.940
138.559
149.050
144.062
145.222
184.060
220.915
Total Expenses - EUR
-
3.017
12.204
20.487
22.361
31.830
32.921
39.042
59.095
72.588
Gross Profit/Loss - EUR
-
20.023
71.295
96.453
116.198
117.220
111.141
106.180
124.965
148.327
Net Profit/Loss - EUR
-
19.562
70.460
95.284
114.812
115.841
109.729
104.757
123.161
141.832
Employees
-
1
1
2
1
2
2
3
3
2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 20.7%, from 183.981 euro in the year 2023, to 220.843 euro in 2024.
The Net Profit increased by 19.359 euro, from 123.161 euro in 2023, to 141.832 in the last year.
Check the financial reports for the company - Medviz Srl
Financial Rating - MEDVIZ SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Medviz Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Medviz Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Medviz Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
161.583 euro in 2024 which includes Inventories of
0 euro, Receivables of
101.510 euro and cash availability of
60.073 euro.
The company's Equity was valued at
141.880 euro, while total Liabilities amounted to
56.165 euro.
Equity increased by 19.359 euro, from 123.210 euro in 2023, to 141.880 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Medviz Srl